YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)
Injured by Premphase?
Premphase (Generic: Conjugated estrogens and Medroxyprogesterone acetate) has been linked to the following side effects: dementia, Alzheimer's disease, stroke, blood clots, pulmonary embolisms, lupus and breast cancer. Premphase is a hormone replacement therapy (HRT) prescribed for menopause symptoms.Approximately 6 million women are taking Prempro to treat post-menopausal hot flashes and other menopause symptoms. However, a recent major study concludes that long-term use of Prempro is dangerous and significantly increases the risk of stroke, blood clots, heart attacks and breast cancer. These results were discovered in the nation's biggest hormone replacement study and were so alarming that the National Institute of Health (NIH) prematurely canceled the study, citing risk to the study's participants. As a result, the study is suggesting that many of the women who use Prempro and other estrogen and progestin combinations should quit taking the medications and talk to their doctors about alternatives.
The evidence is clear that Prempro and other estrogen progestin combinations can harm perfectly healthy women. Women taking Prempro have a 29% higher risk of heart attack, 41% higher risk of stroke and a 26% higher risk of breast cancer. Another study released on May 27, 2003 about the health risks of hormone replacement therapy concluded that the medications can double the risk of dementia and Alzheimer's disease.
Premphase, Premarin and Prempro are manufactured by Wyeth and accounted for about $890 million of the company's $13.9 billion in sales in 2001.
If you or a loved one took Premphase and suffered side effects, please fill out the form at the right for a free case evaluation by a qualified drug side effects attorney.
PremphaseRSS Feed
Premarin, Prempro, Other Hormone Drugs Named in Nevada Lawsuit
Nov 20, 2008 | Parker Waichman Alonso LLP
Wyeth Pharmaceuticals is facing yet another lawsuit over its hormone replacement therapy drugs, Premarin, Prempro and Premphase. This time, the state of Nevada is charging that Wyeth used deceptive practices in selling the drugs. The Nevada attorney general has also targeted Pfizer, Inc.'s Provera.The Nevada lawsuit charges that Wyeth and Pfizer misled consumers about the safety and effectiveness of the hormone therapy drugs. The lawsuit claims that the deception ...
Hormone Replacement Therapy Even for Short Periods Raises Breast Cancer Risk
Jan 16, 2008 | Parker Waichman Alonso LLP
U.S. researchers reported this week that hormone replacement therapy (HRT) significantly raises the risk of an uncommon type of breast cancer. The study found women who took combined estrogen/progestin HRT for three years or more had four times the usual risk of lobular breast cancer. The study, published in the January issue of Cancer Epidemiology, Biomarkers and Prevention, is one of dozens of studies looking to clarify the dangers of taking HRT to treat menopause symptoms. ...
Hormones can raise breast cancer risk
Apr 19, 2007 | AP
Research on two continents signaled more bad news for menopause hormones, offering the strongest evidence yet that they can raise the risk of breast cancer and are tied to a slightly higher risk of ovarian cancer. New U.S. government numbers showed that breast cancer rates leveled off in 2004 after plunging in 2003 the year after millions of women stopped taking hormones because a big study tied them to higher heart, stroke and breast cancer risks. Experts said the leveling off shows that the...
US drop in breast cancer linked to reduced hormone use
Apr 18, 2007 | AFP
A sharp decline in breast cancer rates in the United States in 2003 could be linked to a reduction in the use of hormone replacement therapy, according to research published Wednesday. The research, based on data from the National Cancer Institute, shows that the breast cancer incidence rates in women in the United States fell 6.7 percent in 2003 from the previous year and have since stabilized. The drop corresponds with a rapid decline in prescriptions for hormone replacement therapy (HRT)...
Reduced Use of Prempro and Other Hormone Replacement Drugs Linked to Lower Breast Cancer Rates
Dec 14, 2006 | NewsInferno
Breast cancer rates in the United States dropped 7.2 %, dramatically reversing previous trends which consistently showed rising rates. While the turnaround is surprising news to most, it does not surprise critics of hormone replacement drugs. In 2003, a large federal study linked HRT drugs like Prempro and Premarin, to an increased risk of breast cancer. Within months, millions of women stopped taking estrogen and progestin pills. Medical researchers has exected about 200,000 cases of breast...
Premphase
Quick Facts
Premphase Reference Guide
Generic Name
Conjugated estrogens
Medroxyprogesterone acetate
Date Approved
January 6, 2000
Manufacturer
Wyeth Ayerst
Status
On the market
Approved Uses
Menopause
Serious Side Effects
Dementia
Alzheimer's Disease
Stroke
Blood clots
Pulmonary embolisms
Lupus
Breast Cancer
Related Topics
Premarin
Prempro
Stroke
Breast Cancer
Blood Clots
Defective Drugs
Diseases
Conjugated estrogens
Medroxyprogesterone acetate
Date Approved
January 6, 2000
Manufacturer
Wyeth Ayerst
Status
On the market
Approved Uses
Menopause
Serious Side Effects
Dementia
Alzheimer's Disease
Stroke
Blood clots
Pulmonary embolisms
Lupus
Breast Cancer
Related Topics
Premarin
Prempro
Stroke
Breast Cancer
Blood Clots
Defective Drugs
Diseases
News Feeds
WE ALSO OFFER OUR FIRM NEWS AS RSS/XML FEEDS.
LEARN MORE ABOUT RSS